P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA. (23rd June 2022) - Stegelmann, F.; Jahn, E.; Koschmieder, S.; Heidel, F.; Hochhaus, A.; Hebart, H.; Isfort, S.; Reiter, A.; Bangerter, M.; Waller, C. F.; Wolleschak, D.; Scheid, C.; et al.